Mural Oncology plc [NASDAQ: MURA] surged by $0.03 during the normal trading session on previous day and reaching a high of $2.48 during the day while it closed the day at $2.47.
Mural Oncology plc stock has also loss -3.52% of its value over the past 7 days. However, MURA stock has declined by -39.90% in the 3 months of the year. Over the past six months meanwhile, it has lost -32.14% and lost -23.29% year-on date.
The market cap for MURA stock reached $42.66 million, with 17.26 million shares outstanding and 12.83 million shares in the current float. Compared to the average trading volume of 4.64M shares, MURA reached a trading volume of 111862 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Mural Oncology plc [MURA]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for MURA shares is $11.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on MURA stock is a recommendation set at 2.33. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Raymond James have made an estimate for Mural Oncology plc shares, keeping their opinion on the stock as Outperform, with their previous recommendation back on March 25, 2025. The new note on the price target was released on March 25, 2025, representing the official price target for Mural Oncology plc stock. Previously, the target price had yet another raise to $15, while Rodman & Renshaw analysts kept a Buy rating on MURA stock.
The Average True Range (ATR) for Mural Oncology plc is set at 0.12 The Price to Book ratio for the last quarter was 0.40, with the Price to Cash per share for the same quarter was set at 6.23.
MURA stock trade performance evaluation
Mural Oncology plc [MURA] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -3.52. With this latest performance, MURA shares dropped by -11.79% in over the last four-week period, additionally sinking by -32.14% over the last 6 months – not to mention a drop of -23.53% in the past year of trading.
Mural Oncology plc [MURA]: An insightful look at the core fundamentals
Return on Equity for this stock declined to -66.10%, with Return on Assets sitting at -66.10%.
Earnings per share (EPS) analysis for Mural Oncology plc [MURA] stock
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for MURA. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Mural Oncology plc go to 40.79%.
Mural Oncology plc [MURA]: Institutional Ownership
There are presently around $54.88%, or 63.21%% of MURA stock, in the hands of institutional investors. The top three institutional holders of MURA stocks are: ARMISTICE CAPITAL, LLC with ownership of 1.69 million shares, which is approximately 9.9735%. SOLAS CAPITAL MANAGEMENT, LLC, holding 1.27 million shares of the stock with an approximate value of $$3.98 million in MURA stocks shares; and SOLAS CAPITAL MANAGEMENT, LLC, currently with $$2.63 million in MURA stock with ownership which is approximately 4.94%.
